相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-grade serous carcinomas of the ovary contain very few point mutations
Sian Jones et al.
JOURNAL OF PATHOLOGY (2012)
Fallopian Tube Correlates of Ovarian Serous Borderline Tumors
Anna R. Laury et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Papillary Tubal Hyperplasia: The Putative Precursor of Ovarian Atypical Proliferative (Borderline) Serous Tumors, Noninvasive Implants, and Endosalpingiosis
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas
Alison M. Karst et al.
GYNECOLOGIC ONCOLOGY (2011)
Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior
Belen Canet et al.
HUMAN PATHOLOGY (2011)
Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis
Inigo Espinosa et al.
MODERN PATHOLOGY (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
The Molecular Pathogenesis of Hereditary Ovarian Carcinoma
Barbara M. Norquist et al.
CANCER (2010)
The Origin of Ovarian Cancer - Is It Getting Clearer?
Michael J. Birrer
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
K. Levanon et al.
ONCOGENE (2010)
Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
Bhavana Pothuri et al.
PLOS ONE (2010)
The genesis and evolution of high-grade serous ovarian cancer
David D. L. Bowtell
NATURE REVIEWS CANCER (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas A Clinicopathologic and Molecular Genetic Analysis
Ayse Ayhan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment
Ashok R. Venkitaraman
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Ovarian carcinoma pathology and genetics: recent advances
C. Blake Gilks et al.
HUMAN PATHOLOGY (2009)
The Role of Hepatocyte Nuclear Factor-1β in the Pathogenesis of Clear Cell Carcinoma of the Ovary
Hiroshi Kobayashi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Anaplastic carcinoma in mucinous ovarian tumors - A clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules
Claudia Provenza et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Endocervical Adenocarcinomas With Ovarian Metastases Analysis of 29 Cases With Emphasis on Minimally Invasive Cervical Tumors and the Ability of the Metastases to Simulate Primary Ovarian Neoplasms
Brigitte M. Ronnett et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
Martin Köbel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Joshua Z. Press et al.
BMC CANCER (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
Ann K. Folkins et al.
GYNECOLOGIC ONCOLOGY (2008)
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
C. Blake Gilks et al.
HUMAN PATHOLOGY (2008)
Serous carcinogenesis in the fallopian tube: A descriptive classification
Elke Jarboe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Endometrioid neoplasms with clear cells - A report of 21 cases in which the alteration is not of typical secretory type
Elvio G. Silva et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma
Hyun S. Shvartsman et al.
GYNECOLOGIC ONCOLOGY (2007)
Alternate molecular genetic pathways in ovarian carcinomas of common histological types
Julia Willner et al.
HUMAN PATHOLOGY (2007)
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
David W. Kindelberger et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants
N. L. Sieben et al.
JOURNAL OF PATHOLOGY (2006)
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary
David M. Gershenson et al.
OBSTETRICS AND GYNECOLOGY (2006)
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
M. Takano et al.
BRITISH JOURNAL OF CANCER (2006)
A distinct molecular profile associated with mucinous epithelial ovarian cancer
VA Heinzelmann-Schwarz et al.
BRITISH JOURNAL OF CANCER (2006)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases
R Vang et al.
MODERN PATHOLOGY (2006)
Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary
N Kato et al.
MODERN PATHOLOGY (2006)
Synchronous endometrioid carcinomas of the uterine corpus and ovary:: alterations in the β-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis
JA Irving et al.
HUMAN PATHOLOGY (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Role of serial sectioning in the detection of occult malignancy
CB Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis -: A mutational analysis with immunohistochemical correlation
G Singer et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer
DM Dinulescu et al.
NATURE MEDICINE (2005)
Grading ovarian serous carcinoma using a two-tier system
A Malpica et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma
M Al-Hussaini et al.
HISTOPATHOLOGY (2004)
Borderline ovarian tumors: Key points and workshop summary
SG Silverberg et al.
HUMAN PATHOLOGY (2004)
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: Workshop perspectives
DA Bell et al.
HUMAN PATHOLOGY (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Molecular genetic alterations in endometrioid carcinomas of the ovary:: Similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas
L Catasús et al.
HUMAN PATHOLOGY (2004)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma
A Horiuchi et al.
LABORATORY INVESTIGATION (2003)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary
SY Park et al.
HUMAN PATHOLOGY (2002)
Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: DPc4 assists in identifying metastatic pancreatic carcinomas
HX Ji et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2002)
Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary
H Itamochi et al.
OBSTETRICS AND GYNECOLOGY (2002)
Mucinous tumors of the ovary -: A clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas
IM Rodríguez et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential
MA Crispens et al.
OBSTETRICS AND GYNECOLOGY (2002)
Selectivity of chromatin-remodelling cofactors for ligand-activated transcription
B Lemon et al.
NATURE (2001)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)
Tubal ligation and risk of ovarian cancer
JMJ Piek et al.
LANCET (2001)
β-catenin expression pattern, β-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas
G Moreno-Bueno et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2001)
Mucinous tumors of the ovary - A clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'
KR Lee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
